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Abstract
The bZIP transcription factor Nrf2 has emerged as a pivotal regulator of intracellular redox homeostasis by controlling the
expression of many endogenous antioxidants and phase II detoxification enzymes. Upon oxidative stress, Nrf2 is induced at
protein levels through redox-sensitive modifications on cysteine residues of Keap1, a component of the E3 ubiquitin ligase
that targets Nrf2 for ubiquitin-dependent degradation. The mitogen activated protein kinases (MAPKs) have previously
been proposed to regulate Nrf2 in response to oxidative stress. However, the exact role of MAPKs and the underlying
molecular mechanism remain poorly defined. Here we report the first evidence that Nrf2 is phosphorylated in vivo by
MAPKs. We have identified multiple serine/threonine residues as major targets of MAPK-mediated phosphorylation.
Combined alanine substitution on those residues leads to a moderate decrease in the transcriptional activity of Nrf2, most
likely due to a slight reduction in its nuclear accumulation. More importantly, Nrf2 protein stability, primarily controlled by
Keap1, is not altered by Nrf2 phosphorylation in vivo. These data indicate that direct phosphorylation of Nrf2 by MAPKs has
limited contribution in modulating Nrf2 activity. We suggest that MAPKs regulate the Nrf2 signaling pathway mainly
through indirect mechanisms.
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Introduction
Disruption of redox homeostasis is associated with the toxic
effects of many environmental insults and pathogenesis of aging-
related diseases such as cancer and neurodegenerative disorders
[1,2,3,4,5]. Mammalian intracellular redox homeostasis is main-
tained mainly through transcriptional control of an array of
antioxidative genes upon exposure to environmental insults that
generate oxidative stress. As a key component of such a control
system, the antioxidant response element (ARE) is a conservative
cis-acting element found in the promoter regions of many genes
encoding antioxidants and detoxification enzymes. The corre-
sponding trans-acting factor for the ARE is the nuclear factor
erythroid 2-related factor 2 (Nrf2), a protein belonging to the bZIP
(basic-leucine zipper) transcription factor family [6,7,8].
The Nrf2-ARE system is responsible for both basal and
inducible expression of many genes involved in antioxidant
responses, such as NAD(P)H quinone oxidoreductase 1 (NQO1),
heme oxygenase-1 (HO-1), glutathione S-transferase A1 (GSTA1,
also known as GST-Ya in mouse), glutamate-cysteine ligase (also
known as c-glutamylcysteine synthetase, i.e. cGCS) modifier
subunit (GCLM) and catalytic subunit (GCLC) [9,10,11,12]. The
importance of the Nrf2-ARE system is evidently demonstrated by
findings that Nrf2 knockout mice display significantly increased
sensitivity to chemical toxicants and carcinogens [13,14].
Nrf2 is activated by a plethora of stress inducers, phyto-
antioxidants, and pathological conditions. The current model of
the molecular mechanism for Nrf2 activation is that oxidative
stress modifies cysteine residues of Keap1, a component of the E3
ubiquitin ligase that targets Nrf2 for degradation, resulting in
compromised E3 activity and enhanced Nrf2 protein stability. The
subsequent elevation in Nrf2 protein levels leads to Nrf2 nuclear
accumulation, increased ARE-Nrf2 binding, and transactivation
of its downstream genes [15,16,17,18,19,20,21]. In addition to the
primary mode of regulation on its protein stability controlled by
Keap1, Nrf2 is also regulated at multiple levels such as
nucleocytoplamic trafficking, acetylation, and phosphorylation
[22,23,24,25].
The mitogen-activated protein kinases (MAPKs) are a family of
highly related kinases consisting of the extracellular signal-regulated
protein kinases (ERKs), the c-jun N-terminal kinases (JNKs), the p38
kinases and other relatively less characterized kinases, all of which
catalyze phosphorylation on either serine or threonine residues
adjacent to a proline residue. MAPKs are activated in a cascade
fashion, by MAP2Ks (also known as MKKs or MEKs) that are in
turn activated by MAP3Ks (also known as MEKKs, including
ASK1, TAK1, Rafs, etc.) [26]. The MAPK signaling system
responds to diverse stimuli, including oxidative stress, and has been
implicated in Nrf2 induction by many previous reports (Table 1, see
Discussion) [24,25]. However previous studies failed to address
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andspecificphosphorylationeventsonNrf2 orthroughindirectand
less specific mechanisms. It is not even known whether or not
MAPKs phosphorylate Nrf2 in vivo at all. Another question that
remains unanswered is whether MAPKs affect Keap1-mediated
control of Nrf2 protein stability in vivo. Therefore, the exact role of
MAPKs in Nrf2 activation, as well as the underlying molecular
mechanism, remains poorly understood.
Here we report the first evidence indicating that Nrf2 is
phosphorylated at several serine and threonine residues by
MAPKs in vivo. Combined alanine substitution of those residues
leads to only a very moderate decrease in the transcriptional
activity of Nrf2, most likely due to a slight reduction in its nuclear
accumulation. More importantly, Nrf2 protein stability, which is
primarily controlled by Keap1, is not altered in vivo by Nrf2
phosphorylation. These data indicate that direct phosphorylation
of Nrf2 by MAPKs has limited contribution in modulating the
Nrf2 signaling pathway. We propose that MAPKs regulate Nrf2
mainly through indirect mechanisms.
Materials and Methods
Recombinant DNA molecules
Plasmids expressing JNK1/2, ERK2, p38, MEKK3 and
MEKK4 were generous gifts from Dr. Richard R. Vaillancourt
at University of Arizona. Plasmids for HA-Nrf2 and Keap1-CBD
proteins have been previously described [27]. The Nrf2 mutants
were generated by site-directed mutagenesis using the PCR and
Dpn1 based method as described before [28]. The human NQO1-
ARE TATA-Inr luciferase reporter plasmid and the mouse
GSTA1-ARE TATA-Inr luciferase reporter plasmid were report-
ed previously [28,29]. Renilla luciferase plasmid pGL4.74[hRluc/
TK] was purchased from Promega.
Cell culture, transfection and chemicals
HEK293T, MDA-MB-231 and NIH3T3 cells were purchased
from ATCC. Cells were maintained in either Dulbecco’s modified
Eagle’s medium (DMEM) or Eagle’s minimal essential medium
(MEM) in the presence of 10% fetal bovine serum (FBS).
Table 1. Summary of key findings by previous studies showing the involvement of MAPKs in Nrf2 activation.
Manipulation of MAPKs Readout of Nrf2 activity Changes of Nrf2 activity Nrf2 inducers Ref
PD98059 or DN ERK2 NQO1 enzyme, GSTA1 ARE-luc 30–60% decrease tBHQ, SF [42]
PD98059 and SB202190 GCS mRNA, ARE-luc, ARE binding ,100% decrease PDTC [43]
MEKK1, TAK1, ASK1, MKK4/6, JNK1 GSTA1 ARE-luc 3–18 fold increase [44]
p38 GSTA1 ARE-luc 30–40% decrease tBHQ [44]
SB203580, DN p38 or DN MKK3 NQO1 enzyme, GSTA1 ARE-luc 40–50% increase BHA, SF, b-NF [45]
SB202191 or DN p38a HO-1 E1-luc 70–80% decrease CdCl2 [46]
PD98059, DN JNK1/2 or DN ERK1/2 HO-1 E1-luc no change CdCl2 [46]
PD98059 and SB202191 nuclear Nrf2 protein 80–90% decrease PDTC [34]
JNK1 ARE-luc ,6 fold increase PEITC [47]
DN JNK1 ARE-luc 20–70% decrease PEITC [47]
MEKK1, TAK1, ASK1, MEK1/5, ERK2/5 ARE-luc 1.5–5 fold increase [35]
U0126 or ERK1 knockout ARE-luc, ARE binding, Nrf2 protein block induction hyperoxia [48]
SP600125 or SB203580 Nrf2 protein block induction gallic acid [49]
Raf knockout Nrf2 nulear entry no change curcumin [50]
p38a, b, c, d HO-1 promoter-luc 20–80% decrease SF [33]
U0126, DN ERK2 or DN JNK1 ARE-luc 20–60% decrease BHA [51]
MKK4 and JNK1 ARE-luc, HO-1 3 fold increase PEITC [52]
DN ERK2 or DN JNK1 ARE-luc 40–50% decrease PEITC [52]
PD98059 and SB203580 nuclear Nrf2 protein block induction 4-HNE [53]
U0126 or DN MEK nuclear Nrf2 protein block induction PGG [54]
PD169316 or p38 siRNA HO-1 protein, nuclear Nrf2 protein .50% decrease PDT [55]
PD98059 or SB203580 Nrf2 nulear entry block induction quercectin [56]
PD98059 or U0126 nuclear Nrf2 protein, ARE-luc ,60% decrease D3T [57]
U0126 Nrf2 nuclear entry, ARE-luc block induction Triphlorethol-A [58]
PD98059 nuclear Nrf2 protein block induction eupatilin [59]
PD98059 nuclear Nrf2, ARE-luc, ARE binding block induction MT-III [60]
U0126, DN ERK1 or DN ERK2 HO-1 protein, ARE-luc 30–80% decrease 15d-PGJ2 [61]
U0126 nuclear Nrf2 protein block induction EGCG [62]
Manipulation of MAPKs activities, by either using kinase inhibitors or genetic engineering of MAPKs by overexpressing wild-type or dominant-negative (DN) kinases, was
used as the major approach to assess the role of MAPKs in Nrf2 activation. PD98059: MEK1 inhibitor; SB202190: p38 inhibitor; SB203580: p38 inhibitor; U0126 MEK1/2
inhibitor; SP6000125: JNK inihibitor; luc: luciferase reporter gene; PDTC: pyrrolidine dithiocarbamate; b-NF: beta-naphthoflavone; BHA: tert-butylhydroxyanisole; PEITC:
phenethylisothiocyanates; PDT: photodynamic therapy; 4-HNE: 4-hydroxynonenal; D3T: 3H-1,2-dithiole-3-thione; PGG: 1,2,3,4,6-penta-O-galloyl-b-D-glucose; ISMC: ileal
smooth muscle cell; MTIII: metallothionein-III; EGCG: Epigallocatechin gallate.
doi:10.1371/journal.pone.0006588.t001
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BRL) according to the manufacturer’s instructions.
Immunoblot, immunoprecipitation, and
immunofluorescence analysis
Antibodies against the HA epitope (Santa Cruz), chitin-binding
domain (CBD) (New England Biolab), a-tubulin (Santa Cruz), and
phosphorylated serine/threonine followed by a proline (pS/TP)
(Abcam) were purchased from commercial sources. For detection of
protein expression in total cell lysates, cells were lysed in sample
buffer (50 mM Tris-HCl [pH 6.8], 2% SDS, 10% Glycerol,
100 mM DTT, 0.1% bromophenol blue) 48 hours following
transfection. For immunoprecipitation assays, cells were lysed in
RIPA buffer (10 mM sodium phosphate pH [8.0], 150 mM NaCl,
1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS) containing
1 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride
(PMSF), and a protease inhibitor cocktail (Sigma). Cell lysates were
pre-cleared with protein A beads and incubated with HA antibody-
conjugated beads (Santa Cruz) or chitinbeads (New England Biolab)
overnight at 4uC. After washing three times with RIPA buffer,
immunoprecipitated complexes were eluted in sample buffer by
boiling for 5 minutes, electrophoresed through SDS-polyacrylamide
gels, and subjected to immunoblot analysis. Indirect immunofluo-
rescence analysis was performed as described before using anti-HA
primary antibodies [28].
In vivo phosphorylation of Nrf2
To detectphosphorylatedNrf2 invivobyimmunoblot,transfected
cells were lysed by boiling in a buffer containing 2% SDS, 150 mM
NaCl, 10 mM Tris-HCl and 1 mM DTT. This rapid lysis
procedure inactivated cellularphosphatasesandtherefore preserved
phosphorylated-Nrf2 conjugates present in cells prior to lysis. These
lysates were then diluted five-fold in buffer lacking SDS, followed by
immunoprecipitation with HA antibody-conjugated beads.
Mass spectrometry
Mass spectrometry analysis was performed by the Harvard
Taplin mass spectrometry core facility. Briefly, immunoprecipitated
proteins were visualized by Coomassie staining and recoverd from
the gel. Excised gel bands were cut into approximately 1 mm
3
pieces. Gel pieces were then subjected to a modified in-gel trypsin
digestion procedure [30], followed by washing and dehydration
with acetonitrile for 10 min. After removal of acetonitrile, gel pieces
were completely dried in a speed-vac, and rehydrated with 50 mM
ammonium bicarbonate solution containing 12.5 ng/ml modified
sequencing-grade trypsin (Promega, Madison, WI) at 4uC. After
45 min., the excess trypsin solution was removed and replaced with
50 mMammoniumbicarbonatesolutiontojustcoverthegelpieces.
Sampleswerethen incubatedat 37uC overnight. Peptides were later
extracted by removing the ammonium bicarbonate solution,
followed by one wash with a solution containing 50% acetonitrile
and 5% acetic acid. The extracts were then dried in a speed-vac
(,1 hr). The samples were then reconstituted in 5–10 ml of HPLC
solvent A (2.5% acetonitrile, 0.1% formic acid). A nano-scale
reverse-phaseHPLCcapillarycolumnwascreated bypacking5 mm
C18 spherical silica beads into a fused silica capillary (100 mm inner
diameter x,12 cm length) with a flame-drawn tip. After equili-
brating the column each sample was loaded via a Famos auto
sampler (LC Packings, San Francisco CA) onto the column. A
gradient was formed and peptides were eluted with increasing
concentrations of solvent B (97.5% acetonitrile, 0.1% formic acid).
As each peptide was eluted they were subjected to electrospray
ionization and then they entered into an LTQ Orbitrap mass
spectrometer (ThermoFinnigan, San Jose, CA). Eluting peptides
were detected, isolated, and fragmented to produce a tandem mass
spectrum of specific fragment ions for each peptide. Peptide
sequences (and hence protein identity) were determined by
matching protein or translated nucleotide databases with the
acquired fragmentation pattern by the software program, Sequest
(ThermoFinnigan, San Jose, CA).
Reporter gene assay
A plasmid encoding renilla luciferase was included in all samples
to control for transfection efficiency. Reporter assays were
performed using the Dual-Luciferase reporter gene assay system
(Promega). Nrf2 inducers tert-butylhydroquinone (tBHQ), sulfo-
raphane (SF), sodium arsenite (As), and cadmium chloride (Cd)
were purchased from Sigma (St. Louis, MO). Hydrogen peroxide
(H2O2) was purchased from Mallinckrodt (Phillipsburg, NJ).
Oridonin (Orid, also known as rubescensin A) was purchased from
LKT Laboratories (St. Paul, MN). 15-Deoxy-D-12, 14-prostaglan-
din J2 (PGJ2) was a kind gift from Dr. John W. Regan at
University of Arizona.
qRT-PCR
The real-time RT-PCR analysis and primer/probe sequence
information was previously described [28,31,32].
Statistical test
Student’s t- test was used to determine the significant difference
between two samples from three assays in reporter gene analysis
and qPCR analysis.
Results
Nrf2 is phosphorylated in vivo at multiple sites by MAPKs
Purified recombinant GST-Nrf2 protein has been shown to be
phosphorylated by immunoprecipitated p38 MAPKs in vitro [33].
However it is not clear whether Nrf2 is a bona fide substrate of
MAPKs in vivo. To address this question, HEK293T cells were
cotransfected with expression vectors for HA-tagged Nrf2 and the
indicated MAPKs (Figure 1A). Cell lysates were immunoprecipi-
tated with anti-HA antibodies. The immunoprecipitates were
analyzed by immunoblot using antibodies that recognize phosphor-
ylated serine or threonine residue adjacent to a proline (pS/TP), the
consensus motif phosphorylated by MAPKs. The phosphorylation
of Nrf2 is significantly enhanced in the presence of overexpressed
MAPKs or their upstream kinases (Figure 1A, compare lane 1 with
others). The phosphorylation antibody is specific to MAPK
consensus sites, as demonstrated by its failure to recognize non-
MAPK phosphorylation sites such as IKK sites (Figure S2).
To identify the phosphorylation sites on Nrf2 by endogenous
kinases, HEK293T cells were transfected with an expression
vector for HA-tagged human Nrf2. Nrf2 proteins were purified by
immunoprecipitation with anti-HA antibodies, separated by SDS-
PAGE, and visualized by coomassie blue staining. The gel
containing the Nrf2 protein was isolated and subjected to mass
spectrometry analysis using LC-MS/MS. Five phosphorylated
serine or threonine residues (S215, S408, S558, T559 and S577)
were identified (Figure 1B–F). Three of them (S215, S408, S577)
fit consensus sites for MAPKs, while the other two (S558 and
S559) do not. All five sites were subsequently characterized,
individually and combined.
Abolishing Nrf2 phosphorylation by mutation causes a
limited decrease in the transcriptional activity of Nrf2
Genetic approaches were taken to explore the function of
phosphorylation on Nrf2. Single or combined alanine substitu-
Nrf2 Phosphorylation by MAPK
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transcriptional activity of the resultant Nrf2 mutants were tested
in the ARE-dependent reporter gene assays using the ARE
sequence taken from either the NQO1 gene promoter (Figure 2A)
or the GSTA1 gene promoter (Figure 2B). In both cases, only the
combined mutation of all five phosphorylation sites caused a
slight decrease in Nrf2 transcriptional activity (Figure 2A and 2B).
More importantly, none of the mutations, whether single or
combined, caused obvious changes in Nrf2 protein levels
(Figure 2C).
Figure 1. Nrf2 is phosphorylated in vivo at multiple sites by MAPKs. (A) HEK293T cells were cotransfected with expression vectors for HA-
tagged Nrf2 and the indicated MAPKs. Cells were lysed in denaturing conditions. Cell lysates were diluted and immunoprecipitated with anti-HA
antibodies. The immunoprecipitated protein was analyzed by immunoblot with antibodies specific for phosphorylated serine or threonine residues
adjacent to a proline (pS/TP) (Abcam ab9344). p-Nrf2: phosphorylated Nrf2; Tub: tubulin. (B–F) Identification of distinct phosphorylation sites by
tandem mass spectrometry analysis. Nrf2 proteins were purified through immunoprecipitation with anti-HA antibodies from HEK293T cells
overexpressing HA-tagged Nrf2. The Nrf2 protein was size-separated by SDS-PAGE and visualized by Coomassie blue staining. The gel containing the
Nrf2 protein was isolated and subjected to mass spectrometry analysis. m/z: mass to charge ratio.
doi:10.1371/journal.pone.0006588.g001
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alanines was named ‘‘5A’’ and was subjected to subsequent
analysis, since it seemed to have a slightly compromised ability in
transactivating the ARE-dependent genes. Abolishment of Nrf2
phosphorylation in the Nrf2-5A mutant was confirmed by the in
vivo phosphorylation assay (Figure 3A). All three MAPK consensus
sites (S215, S408 and S577) seem to contribute to the overall
phosphorylation level of Nrf2 in the presence of overexpressed
MAPKs (Figure S1). If the antibody has no bias towards the
context sequences around the consensus phosphorylation sites,
S408 seems to be the most dominant site. None of the single
mutations was able to abolish Nrf2 phosphorylation as well as the
combined 5A mutation, suggesting a redundancy in phosphory-
lation sites (Figure S1). To further test the effects of phosphory-
lation on the transcriptional activity of Nrf2, mRNA expression of
Nrf2 target genes was analyzed by qRT-PCR in HEK293T cells
overexpressing either Nrf2-WT (wild-type) or Nrf2-5A mutant
(Figure 3C). Loss of phosphorylation causes a minor or only
moderate decrease in the expression of Nrf2 downstream gene
NQO1, HO-1, and GCLM (Figure 3C), without affecting Nrf2
protein levels (Figure 3B and 3C).
Phosphorylation of Nrf2 slightly increases the response
of Nrf2 to several chemical inducers without affecting
Keap1-mediated control of Nrf2 protein levels
To test whether phosphorylation of Nrf2 alters its behavior in
response to different inducers, reporter gene analysis was
performed on MDA-MB-231 cells overexpressing Keap1 and
either Nrf2-WT or Nrf2-5A. Cells were treated with different Nrf2
inducers for 16 hrs prior to analysis. Altered response between
Nrf2-WT and Nrf2-5A was only observed in the presence of
relatively potent Nrf2 inducers (Figure 3D). The protein levels of
Nrf2-WT and Nrf2-5A were increased to a similar extent in
response to all inducers tested, suggesting that phosphorylation
does not have any effect on Nrf2 protein stability that is primarily
controlled by Keap1 (Figure 3E).
Phosphorylation of Nrf2 by MAPKs does not affect the
interaction between Nrf2 and Keap1 in vivo
Keum et al. have reported that phosphorylation of Nrf2 by p38
MAPKs increased the interaction between Nrf2 and Keap1 in an
in vitro GST-pulldown experiment [33]. To test whether similar
effects can be observed in vivo, HEK293T cells were co-transfected
with an expression vector for either HA-tagged Nrf2-WT or Nrf2-
5A, along with expression vectors for CBD-tagged Keap1, and the
indicated MAPK. Cell lysates were pulled-down with chitin beads
and the precipitated protein complexes were analyzed by
immunoblot with anti-HA and anti-CBD antibodies (Figure 4A).
The interaction between Nrf2 and Keap1 was not affected by the
phosphorylation status of Nrf2, consistent with the finding that
phoshorylation of Nrf2 does not affect its protein stability
(Figure 3E).
Phosphorylation of Nrf2 moderately enhances its nuclear
accumulation
Nuclear translocation of Nrf2 protein is essential for Nrf2 to
transactivate its downstream genes. To test whether phosphory-
lation of Nrf2 alters its nuclear accumulation, NIH3T3 cells were
transfected with the expression vector for Nrf2-WT or Nrf2-5A in
the presence or absence of the expression vector for Keap1 to
mimic basal or induced conditions, respectively. The subcellular
localization of Nrf2 was determined by indirect immunofluores-
cence analysis with anti-HA antibodies. There was a slight
Figure 2. Combined alanine substitution on all phosphoryla-
tion sites causes only a moderate decrease in the transcrip-
tional activity of Nrf2. (A) MDA-MB-231 cells were cotransfected
with expression vectors for the GSTA1-ARE-dependent firefly luciferase,
the TK-Renilla luciferase, and the indicated Nrf2 mutant. Luciferase
reporter gene activities were analyzed using the Promega dual-
luciferase reporter gene assay system. WT: wild-type; TK: thymidine
kinase promoter; Inr: initiator. Relative luciferase activities and standard
deviations were calculated from three independent assays. * p,0.05
when compared to WT. (B) Reporter gene assay was performed as
described above using NQO1-ARE-dependent luciferase reporter gene
construct in MDA-MB-231 cells. (C) Total cell lysates from one of the
reporter gene assays were subjected to immunoblot analysis with anti-
HA antibodies for detection of Nrf2.
doi:10.1371/journal.pone.0006588.g002
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HEK293T cells were cotransfected with expression vectors for HA-tagged Nrf2 and JNK2. Cell lysates were immunoprecipitated with anti-HA
antibodies. The immunoprecipitated protein was analyzed by immunoblot with antibodies specific for phosphorylated serine or threonine residue
adjacent to a proline (pS/TP) (Abcam ab9344). wt: wild-type; 5A: the mutant with combined alanine substitution on all five phosphorylation sites. (B–
C) HEK293T cells overexpressing either Nrf2-WT or Nrf2-5A were subjected to immunoblot (B) and qRT-PCR analysis (C). The error bars indicate the
standard deviations calculated from triplicate samples. * p,0.05 when compared to wt. (D) MDA-MB-231 cells were cotransfected with expression
vectors for the GSTA1-ARE-dependent luciferase reporter gene, Keap1, and the indicated Nrf2. Cells were treated with several Nrf2 inducers for 16 hrs
prior to reporter gene analysis. tBHQ: tert-butylhydroquinone (50 mM); SF: sulforaphane (20 mM); PGJ2: 15-Deoxy-D-12,14-prostaglandin J2 (10 mM);
As: sodium arsnite (20 mM); Orid: Oridonin (10 mM); Cd: cadmium chloride (20 mM); H2O2: hydrogen peroxide (500 mM). Error bars indicate standard
deviations calculated from three independent assays. * p,0.05 when compared to wt in the same treatment group. (E) Total cell lysates from the
above reporter gene assay were analyzed by immunoblot.
doi:10.1371/journal.pone.0006588.g003
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WT, in the absence of Keap1, as shown in representative pictures
(Figure 4B) and quantification data (Figure 4C).
Discussion
Many previous studies have shown that MAPKs play a role in
the induction of Nrf2. Table 1 summarizes key findings of all
previous studies that support the involvement of MAPKs in Nrf2
activation. Manipulation of the catalytic activity of MAPKs, either
through pharmaceutical intervention (kinase inhibitors) or genetic
engineering (overexpression of wild-type or dominant-negative
kinases, siRNA-mediated knockdown, or gene knockout), coupled
with a readout of Nrf2 activity (ARE-dependent luciferase reporter
gene, or Nrf2 nuclear accumulation), was used as the major
approach to address the potential role of MAPKs on Nrf2
(Table 1). All three well-characterized categories of MAPKs
(ERKs, JNKs, and p38) have been implicated in modulating Nrf2,
with some contradictory results among different groups. Since
MAPKs regulate bewilderingly diverse cellular programs, it is not
clear whether the observed effects of MAPKs on Nrf2 are highly
specific or just bystander effects. It remains elusive whether
MAPKs regulate Nrf2 through direct phosphorylation of Nrf2 or
through indirect mechanisms. Furthermore, it is not known
whether or not MAPKs phosphorylate Nrf2 in vivo at all. Another
key question that remains open is whether MAPKs affect Nrf2
protein stability that is primarily controlled by Keap1. Therefore,
the exact role of MAPKs in Nrf2 activation, as well as the
underlying molecular mechanism, remains poorly understood.
In this study, we report the first evidence that Nrf2 is
phosphorylated by MAPKs in vivo. We have identified the major
phosphorylation sites and used site-mutagenesis to decipher the
function of direct phosphorylation of Nrf2 by MAPKs. As
demonstrated by data obtained from ARE-dependent luciferase
reporter gene assay and qRT-PCR analysis, a loss of Nrf2
phosphorylation caused only moderate changes in the transcription-
al activity of Nrf2 (Figure 2 and 3). The Keap1-mediated control of
Nrf2 protein levels was not affected by Nrf2 phosphorylation in vivo
under both basal and induced conditions (Figure 3E), nor was the
interaction between Nrf2 and Keap1 (Figure 4A). However, the
nuclear accumulation of Nrf2 was slightly enhanced by its
phosphorylation (Figure 4B and 4C). We concluded that direct
phosphorylation of Nrf2 by MAPKs has a limited contribution in
regulating the Nrf2-dependent antioxidant responses.
We are aware of the fact that our mass spectrometry analysis
may not have identified all phosphorylated residues on Nrf2.
There might be signal-induced Nrf2 phosphorylation on specific
sites that were missed in the current identification procedure
whereby overexpressed Nrf2 protein itself was purified from
HEK293T cells under basal conditions followed by LC-MS/MS.
However, the fact that the Nrf2-5A mutant has significantly
decreased phosphorylation levels compared to wild-type Nrf2 in
the presence of overexpressed JNK2 suggests that these five
residues are the major targets of phosphorylation in vivo (Figure 3A).
Neither inducible ARE-dependent transcription nor inducible
Nrf2 protein levels was dramatically altered by combined
mutations on the identified phosphorylation sites in the presence
of several Nrf2 inducers such as tBHQ, sulforaphane, PGJ2,
arsenite or cadmium, suggesting that phosphorylation at these sites
has limited contribution in regulating inducible Nrf2 signaling
(Figure 3D and 3F). Additionally, in an experiment without using
mutations, overexpression of MAPKs failed to cause any
observable effect on the interaction between wild-type Nrf2 and
Keap1 (Figure 4A, lane 1–5), although Nrf2 phosphorylation was
Figure 4. Phosphorylation of Nrf2 moderately enhances its
nuclear accumulation without affecting the interaction be-
tween Nrf2 and Keap1. (A) HEK293T cells were cotransfected with
expression vectors for the indicated MAPKs, HA-tagged Nrf2, and CBD-
tagged Keap1. Cells were harvested and lysed in RIPA buffer. Cell lysates
were pulled-down with chitin beads and analyzed by immunoblot with
anti-HA and anti-CBD antibodies. CBD: chitin binding domain; wt: wild-
type; 5A: mutant with combined alanine substitution on all five
phosphorylation sites. (B) NIH3T3 cells were transfected with expres-
sion vectors for the indicated Nrf2 protein and Keap1. The subcellular
localization of Nrf2 was determined by indirect immunofluorescence
analysis with anti-HA antibodies. (C) Quantification analysis of the
immunofluorescence assay. At least 100 positively stained cells were
examined by fluorescence microscopy. Percentages of cells in which
Nrf2 was localized predominantly in the cytosol, the whole cell, or the
nucleus were presented as a bar graph.
doi:10.1371/journal.pone.0006588.g004
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Collectively, these data suggest that direct phosphorylation of Nrf2
plays a limited role in regulating Nrf2 activity.
Consistent with our data, Zipper and Mulcahy showed that
mutational disruption of six MAPK consensus sites in Nrf2
(including S215, S408, S577 that were also characterized in this
study) failed to significantly change the GCLM ARE-dependent
reporter gene activities in the absence or presence of pyrrolidine
dithiocarbamate (PDTC), an Nrf2 inducer [34]. Here we provide
additional evidencethat mutationaldisruptionofthesesitesdoesnot
dramatically alter the endogenous mRNA levels of NQO1, HO-1
or GCLM (Figure 3C), excluding possibilities that phosphorylation
might interfere with molecular events that are specific to native
chromosomal architectures. In addition, we showed that neither
Nrf2 protein levels nor ARE-dependent luciferase activities were
dramatically altered by the combined mutation in cells either left
untreated or treated with divergent Nrf2 inducers, such as tBHQ,
sulforaphane, PGJ2, arsnite, oridonin, cadmium and H2O2
(Figure 3E), making it a much less attractive hypothesis that
phosphorylation might be involved in the action of some particular
Nrf2 inducers, if not all. Furthermore, we performed a co-
immunoprecipitation assay and directly demonstrated that the
physical interaction between Nrf2 and Keap1 was not altered in vivo
in the presence of overexpressed MAPKs or with Nrf2 phosphor-
ylation-deficient mutants (Figure 4A). Another previous report from
Kong and colleagues also showed that site-directed mutagenesis of
Nrf2 at several MAPK consensus sites did not affect the
transactivation activity of Nrf2, although these sites do not overlap
with the sites characterized in our present study [35]. Taken
together, MAPK-mediated regulation of the Nrf2 signaling
pathway is not likely to be through direct phosphorylation of Nrf2.
One possible indirect mechanism is translational control on
Nrf2 protein synthesis by MAPKs. MAPKs have been shown to
modulate mTOR signaling pathways in controlling eukaryotic
initiation factor 4 (eIF4) complex assembly, a critical step in Cap-
dependent translational initiation, through inhibiting tuberous
sclerosis complex 2 (TSC2) and activating 90-kD ribosomal
protein S6 kinases (RSKs) [36,37]. MAPKs also promote
phosphorylation of eIF4E, eIF4B-BP1, and translation elongation
factor 2 kinase (eEF2 kinase) through MAPK-interacting kinase 1
and 2 (Mnk1/2), mitogen- and stress-activated protein kinase 1
(Msk1), and MAPK-activated kinase 2/3 (MK2/3), respectively,
which is thought to enhance translation of some mRNAs
[36,37,38,39]. On the other hand, Nrf2 has been shown to be
regulated at the translational level under several conditions
[40,41]. Thus, MAPKs-mediated indirect control of Nrf2 protein
synthesis, along with the moderate role of direct phosphorylation
on Nrf2, may represent the underlying mechanism by which
MAPKs regulates the Nrf2 signaling pathway.
Supporting Information
Figure S1 HEK293T cells were co-transfected with expression
vectors for HA-Nrf2 wild-type or mutants and different kinases.
Cell lysates were collected in denaturing conditions, and
phosphorylation analysis was performed as described in Fig. 1A
and 3A. All three sites (S215, S408 and S577) contribute to the
overall phosphorylation level of Nrf2 in the presence of all four
kinases.
Found at: doi:10.1371/journal.pone.0006588.s001 (0.81 MB TIF)
Figure S2 HEK293T cells were co-transfected with expression
vectors for NF-kB p65, along upstream kinases IKKa and IKKb
in HEK293T cells. Phosphorylation of p65 at S536 by IKKs was
confirmed by an antibody that recognizes this site-specific
modification (Cell Signaling, Cat# 3033S). The antibody for
phospho-S/TP did not pick up any signal above background,
indicating the specificity of this antibody.
Found at: doi:10.1371/journal.pone.0006588.s002 (0.83 MB TIF)
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